Skip to content

Addiction: all studies

Page 331 of 859: studies 3,301 to 3,310 of 8,590, newest first. Back to the addiction overview

Research

Ketamine induced gut microbiota dysbiosis and barrier and hippocampal dysfunction in rats.

iScience November 15, 2024 Lei Xie, Zelin Zhuang, Baowen Guo et al. 5 citations

The microbiota-gut-brain axis (MGBA) plays a pivotal role in drug addiction. However, the pathophysiological mechanism of MGBA in ketamine addiction remains elusive. The present study investigated the ketamine-induced gut microbiota disorders, intestinal barrier dysfunction, and the alterations in brain function, using a conditioned place preference (CPP) model of ketamine addiction in rats....

Knowledge, attitudes, and concerns about psilocybin and MDMA as novel therapies among U.S. healthcare professionals.

Scientific Reports November 14, 2024 Erin Wang, David S. Mathai, Natalie Gukasyan et al. 18 citations

Psychedelic-assisted therapy (PAT) with substances like psilocybin and MDMA has shown promise for conditions including depression and post-traumatic stress disorder. Psilocybin and MDMA may become approved medicines in the coming decade. This study assessed knowledge and attitudes regarding PAT among 879 U.S. healthcare professionals via anonymous online survey. Multivariable linear regression...

Advances in Psychedelic Therapeutics: Novel Prodrugs and Derivatives for Enhanced Mental Health Treatment.

ACS Medicinal Chemistry Letters November 11, 2024 Robert B. Kargbo

High Resolution Image Download MS PowerPoint Slide Recent innovations in psychedelic research have led to the development of novel compounds designed to enhance the therapeutic potential of psilocin and related tryptamines. This Patent Highlight reviews three essential patents that focus on improving the stability, bioavailability, and efficacy of these compounds for treating mental health...

The Unity of Consciousness and the Practical Ethics of Neural Organoid Research

Neuroethics November 9, 2024 Yoshiyuki Hayashi, Ryoji Sato

This article investigates a critical yet underexplored structural aspect of consciousness in the context of the practical ethics of neural organoid research: the unity of consciousness. We advocate for the necessity of the unified field, which has garnered substantial support from both philosophical and empirical standpoints, although the debate remains unresolved. We highlight the brainstem as...

Amid magic and menace: psychiatrists’ attitudes to psilocybin therapy

Irish Journal of Psychological Medicine November 7, 2024 Andrew Gribben, Tara Burke, Colm Harrington et al. 5 citations

Abstract Objectives: Understanding variations in knowledge and attitudes of psychiatrists to psilocybin therapy is important for the collective discourse about the potential impact on clinical practice and public health in Ireland. Methods: A 28-item questionnaire was designed based on previous studies and distributed to psychiatrists in Ireland via online mailing lists and at in-person...

DOI: 10.1017/ipm.2024.49 (opens in new tab) Full text (opens in new tab) Psychiatrist attitudes Irish healthcare Hallucinogens Psilocybin therapy +4

Masking Influences: A Systematic Review of Placebo Control and Masking in Psychedelic Studies

Journal of Psychoactive Drugs November 6, 2024 Aleksandra Barstowe, Petri Kajonius 8 citations

Psychedelic-assisted therapy is becoming increasingly acknowledged as an effective therapeutic intervention for various psychiatric illnesses. However, the evaluation of masking success is rarely reported in trials. The objective of the present systematic review was to evaluate placebo-control and masking in studies exploring psychedelic-assisted therapy. Nine (k = 9) studies dating between...

DOI: 10.1080/02791072.2024.2424272 (opens in new tab) Masking influences Placebo control Psychedelics Systematic review +5

Exploring the substitution of cannabis for alcohol and other drugs among a large convenience sample of people who use cannabis.

Harm Reduction Journal November 5, 2024 Chris Wilkins, Jose Romeo, Marta Rychert et al. 8 citations

The substitution of cannabis for alcohol and other drugs has been conceptualised in a harm reduction framework as where cannabis is used to reduce the negative side-effects, addiction potential, and social stigma of other drugs. There is currently mixed evidence with recent reviews suggesting cannabis co-use patterns may vary by age and ethnicity. Yet few studies have had large enough samples...

Does the Perception of Risk Associated with Psychedelics Use Differ in Physicians According to Their Belief of Effectiveness?

Journal of Psychoactive Drugs November 4, 2024 Aurore Bezo, Bruno Romeo, Y Le Strat et al. 1 citation

The aim of this study was to explore the perception of psychedelics within the medical population. Participants were asked by questionnaire about the potential of abuse, the somatic and psychiatric complications, and the risks of self-harm and aggression associated with the use of psychedelics using Likert Scales. A total of 407 participants were included. In our sample, the following means...

Which comes first, first episode psychosis or cannabis use?

The Brown University Child and Adolescent Behavior Letter November 1, 2024 Alison Knopf

The typical conundrum with cannabis use by adolescents and first episode psychosis — which came first? — was displaced by Steven Batki, M.D., in a plenary session at the Cape Cod Symposium on Addictive Disorders (CCSAD) in September. Bakti, who is a professor of psychiatry at the University of California San Francisco Weill Institute for Neurosciences, presented his conclusions allowing the...

Functional Adaptation in the Brain Habenulo–Mesencephalic Pathway During Cannabinoid Withdrawal

Cells November 1, 2024 Sonia Aroni, Claudia Sagheddu, Marco Pistis et al. 6 citations

The mesolimbic reward system originating from dopamine neurons in the ventral tegmental area (VTA) of the midbrain shows a profound reduction in function during cannabinoid withdrawal. This condition may underlie aversive states that lead to compulsive drug seeking and relapse. The lateral habenula (LHb) exerts negative control over the VTA via the GABA rostromedial tegmental nucleus (RMTg),...

DOI: 10.3390/cells13211809 (opens in new tab) Adaptation eye Kindling Endocannabinoid system Stimulation +1